The conference will feature state-of-the-art presentations by speakers who are world leaders in research and clinical use of polymyxins on a range of topics and
 will host a specialized workshop of EUCAST/EPASG to discuss the setting of new breakpoints for polymyxins.
Colistin and polymyxin B became available in the clinic in the 1950s but fell out of favor, mainly due to concerns about their potential to cause kidney toxicity. They have now come back into use as ‘last line' antibiotics for the treatment of infections caused by Gram-negative pathogens that are resistant to other available antibiotics. During the first several decades after they began to be used, there was little information on how to dose them most effectively. Over the last several years, substantial progress has been made in understanding how to optimize their clinical use.

Attendance Grants
ESCMID provides a number of attendance grants for ESCMID “young scientist
members”. The grant covers the registration fee, but not travel or accommodation costs. Only few Conference places available! Apply now via this link before 22 February 2013. Applicants will be informed about their acceptance by 8 March 2013.

Contact:
Event organiser:
Study Group Organizing Committee: Roger Nation, Australia (Chair), Jian Li, Australia (Deputy Chair), Otto Cars, Sweden, William Couet, France, Mike Dudley, USA, Bob Hancock, Canada, Johan Mouton, Netherlands, David Paterson, Australia, Vincent Tam, US, Ursula Theuretzbacher, Austria, Brian Tsuji, USA, John Turnidge, Australia.
Phone: +4314797024
Email: utheuretzbacher[at]cefaia.com
Website: Polymyxins Congress

Event Secretariat:
Roger Nation
Address: Faculty of Pharmacy and Pharmaceutical Sciences Monash University 381 Royal Parade Parkville, VIC 3052 Australia